- Home
- NUWE
NUWE
Nuwellis Inc.
as 05-10-2024 4:00pm EST
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | 4.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 5.5M |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $3.83 | Next Earning Date: | 05-07-2024 |
| Revenue: | $8,895,000 | Revenue Growth: | 5.35% |
| Revenue Growth (this year): | 19.83% | Revenue Growth (next year): | 23.85% |
Share on Social Networks:
Latest Nuwellis Inc. News
NUWE Breaking Stock News: Dive into NUWE Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration Therapy
GlobeNewswire
5 days ago
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
GlobeNewswire
10 days ago
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
GlobeNewswire
11 days ago
Nuwellis Announces Closing of $2.7 Million Public Offering
GlobeNewswire
11 days ago
Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024
GlobeNewswire
16 days ago
Nuwellis Announces Pricing of $2.7 Million Public Offering
GlobeNewswire
a month ago
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health
Simply Wall St.
2 months ago